Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits E Evangelou, HR Warren, D Mosen-Ansorena, B Mifsud, R Pazoki, H Gao, ... Nature genetics 50 (10), 1412-1425, 2018 | 1361 | 2018 |
Widespread seasonal gene expression reveals annual differences in human immunity and physiology XC Dopico, M Evangelou, RC Ferreira, H Guo, ML Pekalski, DJ Smyth, ... Nature communications 6 (1), 7000, 2015 | 541 | 2015 |
Regulatory T cell responses in participants with type 1 diabetes after a single dose of interleukin-2: a non-randomised, open label, adaptive dose-finding trial JA Todd, M Evangelou, AJ Cutler, ML Pekalski, NM Walker, HE Stevens, ... PLoS medicine 13 (10), e1002139, 2016 | 155 | 2016 |
Million Veteran Program E Evangelou, HR Warren, D Mosen-Ansorena, B Mifsud, R Pazoki, H Gao, ... Genetic analysis of over 1, 1412-1425, 1755 | 114 | 1755 |
A method for gene‐based pathway analysis using genomewide association study summary statistics reveals nine new type 1 diabetes associations M Evangelou, DJ Smyth, MD Fortune, OS Burren, NM Walker, H Guo, ... Genetic epidemiology 38 (8), 661-670, 2014 | 79 | 2014 |
Comparison of methods for competitive tests of pathway analysis M Evangelou, A Rendon, WH Ouwehand, L Wernisch, F Dudbridge Public Library of Science 7 (7), e41018, 2012 | 66 | 2012 |
Integrating multi-OMICS data through sparse canonical correlation analysis for the prediction of complex traits: a comparison study T Rodosthenous, V Shahrezaei, M Evangelou Bioinformatics 36 (17), 4616-4625, 2020 | 55 | 2020 |
An anomaly detection framework for cyber-security data M Evangelou, NM Adams Computers & Security 97, 101941, 2020 | 46 | 2020 |
The link between attention deficit hyperactivity disorder (ADHD) symptoms and obesity-related traits: genetic and prenatal explanations V Karhunen, TA Bond, V Zuber, T Hurtig, I Moilanen, MR Järvelin, ... Translational Psychiatry 11 (1), 455, 2021 | 34 | 2021 |
Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response … LA Truman, ML Pekalski, P Kareclas, M Evangelou, NM Walker, J Howlett, ... BMJ open 5 (12), e009799, 2015 | 29 | 2015 |
Higher thyrotropin leads to unfavorable lipid profile and somewhat higher cardiovascular disease risk: evidence from multi-cohort Mendelian randomization and metabolomic profiling NA van Vliet, MM Bos, CS Thesing, L Chaker, M Pietzner, E Houtman, ... BMC medicine 19, 1-13, 2021 | 25 | 2021 |
Widespread seasonal gene expression reveals annual differences in human immunity and physiology. Nat Commun 6: 7000 XC Dopico, M Evangelou, RC Ferreira, H Guo, ML Pekalski, DJ Smyth, ... | 21 | 2015 |
Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study … J Heywood, M Evangelou, D Goymer, J Kennet, K Anselmiova, C Guy, ... Trials 16, 1-13, 2015 | 15 | 2015 |
Two novel pathway analysis methods based on a hierarchical model M Evangelou, F Dudbridge, L Wernisch Bioinformatics 30 (5), 690-697, 2014 | 14 | 2014 |
Predictability of netflow data M Evangelou, NM Adams 2016 IEEE Conference on Intelligence and Security Informatics (ISI), 67-72, 2016 | 13 | 2016 |
Variational Bayes for high-dimensional proportional hazards models with applications within gene expression M Komodromos, EO Aboagye, M Evangelou, S Filippi, K Ray Bioinformatics 38 (16), 3918-3926, 2022 | 10 | 2022 |
Activity-based temporal anomaly detection in enterprise-cyber security M Whitehouse, M Evangelou, NM Adams 2016 IEEE Conference on Intelligence and Security Informatics (ISI), 248-250, 2016 | 10 | 2016 |
Multi-view data visualisation via manifold learning T Rodosthenous, V Shahrezaei, M Evangelou PeerJ Computer Science 10, e1993, 2024 | 8 | 2024 |
Atopic dermatitis or eczema? Consequences of ambiguity in disease name for biomedical literature mining C Frainay, Y Pitarch, S Filippi, M Evangelou, A Custovic Clinical & Experimental Allergy 51 (9), 1185-1194, 2021 | 7 | 2021 |
MiR-139-5p is a causal biomarker for type 2 diabetes; Results from genome-wide microRNA profiling and Mendelian randomization analysis in a population-based study MMJ Mens, R Mustafa, F Ahmadizar, MA Ikram, M Evangelou, M Kavousi, ... medRxiv, 2021.05. 13.21257090, 2021 | 6 | 2021 |